- The FDA has expanded its urgent investigation into reported deaths following COVID-19 vaccination, now including adults after an initial focus on child fatalities.
- A leaked internal FDA memo concluded that "no fewer than 10" child deaths reported to the VAERS system were related to the vaccine, likely from myocarditis, which it called a "profound revelation."
- The investigation is complicated by concerns over underreporting and alleged data manipulation within the VAERS safety monitoring system, with claims that many adverse event reports were never posted or were deleted.
- There is significant institutional and legal pressure, including a formal petition to revoke the licenses of Pfizer and Moderna vaccines and a shift in federal health policy under new leadership.
- The probe represents a critical moment for vaccine safety transparency, with its outcome expected to heavily impact public trust in health authorities and the legacy of COVID-19 vaccination campaigns.
In a significant escalation, the U.S. Food and Drug Administration (FDA) has expanded a high-stakes investigation into deaths reported following Wuhan coronavirus (COVID-19) vaccination to include adults. This move follows an initial probe focused on child fatalities and marks a critical juncture in the national reckoning over vaccine safety and regulatory transparency.
The FDA has investigated unexplained child deaths following COVID-19 vaccination after years of family pleas and mounting evidence. Centers for Disease Control and Prevention obstruction (CDC) and Vaccine Adverse Event Reporting System (VAERS) underreporting have hidden the true scale of vaccine-related deaths, with data manipulation and deletions exposed. Medical experts demand an immediate halt to vaccinations during the investigation to prevent further tragedies.
A probe broadens in scope and stakes
The FDA's decision to widen its investigation represents a substantial shift. The inclusion of adults suggests the agency's concerns may not be isolated to younger age groups, potentially implicating the broader vaccinated population.
Central to the investigation's gravity is the nature of VAERS data. As of late August, the system contained 38,773 reports of deaths across all age groups. However, experts warn VAERS captures only a fraction of potential adverse events. A 2022 analysis alleged that one-third of COVID-19 vaccine adverse event reports were never posted publicly or were later deleted, forming a contentious backdrop for the FDA's actions.
The adult probe follows a leaked internal FDA memo outlining a review of 96 child deaths reported to VAERS. It concluded that "no fewer than 10" were related to the COVID-19 vaccine, likely due to myocarditis. The memo’s author called it a "profound revelation," acknowledging vaccines had killed American children, and noted the figure was an underestimate.
Myocarditis: The known risk at the heart of the debate
Myocarditis has been an acknowledged risk associated with mRNA vaccines, particularly in young males. Regulators have maintained that the benefits outweigh this risk. However, the FDA memo directly links this condition to fatal outcomes, moving the discussion from managing a side effect to confronting a potential cause of death.
Adding legal pressure, Children's Health Defense filed a formal petition demanding the revocation of the licenses for Pfizer and Moderna's COVID-19 vaccines, arguing they were granted without meeting standard legal requirements. The FDA is obligated to review and respond within 180 days.
Political and institutional turbulence
This investigation unfolds within a transformed environment. The current administration, under Health and Human Services Secretary Robert F. Kennedy Jr., has actively intervened in vaccine policy. Furthermore, the CDC's reconstituted vaccine advisory committee has shifted guidance to emphasize individual decision-making, creating a patchwork of conflicting advice.
This American action echoes global concerns. In the U.K., an All-Party Parliamentary Group for COVID-19 Vaccine Damage has been established. In the EU, regulators approved shots for young children as independent analyses questioned the risk-benefit ratio. New research examines the spike protein's role in immune evasion, and investigations into unexplained mortality spikes often face calls to consider vaccine effects.
"Vaccine safety is established through rigorous clinical trials that include placebo-controlled designs and comprehensive adverse event monitoring," said BrightU.AI's Enoch. "It requires transparent reporting of all potential side effects to ensure unbiased evaluation of risks. Flaws in trial design or ambiguous safety definitions can undermine confidence in these assessments."
The FDA's decision to investigate adult deaths is a watershed moment. It acknowledges the persistent questions that have trailed the largest vaccination campaign in history. Whether this probe will restore trust or deepen divides remains to be seen. Its outcome will shape the legacy of the COVID-19 vaccines and the public's willingness to heed governmental health directives for generations to come.
FDA head Marty Makary admits vaccine deaths are real. Watch this video.
This video is from the Fritjof Persson channel on Brighteon.com.
Sources include:
Please contact us for more information.
